Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Fish and Richardson
AstraZeneca
Cipla
Teva
UBS
Chubb
Merck
Chinese Patent Office

Generated: August 21, 2017

DrugPatentWatch Database Preview

CEFPODOXIME PROXETIL Drug Profile

« Back to Dashboard

Which patents cover Cefpodoxime Proxetil, and when can generic versions of Cefpodoxime Proxetil launch?

Cefpodoxime Proxetil is a drug marketed by Aurobindo Pharma Ltd, Sandoz, Aurobindo Pharma, Sun Pharm Inds Ltd, and Orchid Hlthcare. and is included in seven NDAs.

The generic ingredient in CEFPODOXIME PROXETIL is cefpodoxime proxetil. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.

Summary for Tradename: CEFPODOXIME PROXETIL

Patents:0
Applicants:5
NDAs:7
Suppliers / Packagers: see list9
Bulk Api Vendors: see list37
Clinical Trials: see list7
Patent Applications: see list1,439
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFPODOXIME PROXETIL at DailyMed

Pharmacology for Tradename: CEFPODOXIME PROXETIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
CEFPODOXIME PROXETIL
cefpodoxime proxetil
FOR SUSPENSION;ORAL065409-001Jun 8, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
CEFPODOXIME PROXETIL
cefpodoxime proxetil
TABLET;ORAL065370-001Jun 11, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CEFPODOXIME PROXETIL
cefpodoxime proxetil
FOR SUSPENSION;ORAL090031-002Jan 14, 2009ABRXNoYes► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
CEFPODOXIME PROXETIL
cefpodoxime proxetil
TABLET;ORAL065083-002Aug 20, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
CEFPODOXIME PROXETIL
cefpodoxime proxetil
TABLET;ORAL065370-002Jun 11, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Cantor Fitzgerald
Healthtrust
Citi
Accenture
Federal Trade Commission
Mallinckrodt
Fish and Richardson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot